Has Frederic Pugliano, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,132 in general payments to Frederic Pugliano, MD across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Frederic Pugliano, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Frederic Pugliano, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Frederic Pugliano, MD

Otolaryngology · Kirkwood, MONPI 1639160310

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,219 of the $6,132 with a category attached, or 68.8%. Intersect ENT, Inc. accounts for 62.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $3,291 and has fallen 64.8% since, to $1,158 in 2025. Among otolaryngology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,132in general payments, 2019–2025

Across 76 payments — averaging $80.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intersect ENT, Inc.$4K
Stryker$551
Medtronic$430
GSK$301
Regeneron Healthcare Solutions, Inc.$247
Sanofi$194
plus $575 from 9 others

What the payments were for

Travel & lodging$1,85830%
Food & beverage$4,21969%
Education$561%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intersect ENT, Inc.	22	$3,835
Stryker	9	$551
Medtronic(2 entities)	6	$430
GSK	6	$301
Regeneron Healthcare Solutions, Inc.	7	$247
Sanofi	8	$194
Johnson & Johnson(2 entities)	2	$149
Checkpoint Surgical, Inc	2	$113
Optinose US, Inc.	6	$98
Integra Lifesciences Corporation	1	$76
Aerin Medical Inc.	2	$43
Phathom Pharmaceuticals, Inc.	2	$40
ARS Pharmaceuticals Operations, Inc.	1	$23
Smith+Nephew	1	$18
Alk-abello, Inc	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PROPEL$3,212
SINUVA$2,875
NUCALA$235
SCOPIS ENT$167
AUDION ET DILATION SYSTEM$167
CLARIFIX$167
XPRESS LOPROFILE$167
RYBREVANT$136
CARVYKTI$136
ENTELLUS - XPRESS ENT DILATION SYSTEM$131
XPRESS ENT DILATION SYSTEM$128
ENDOSCOPIC SINUS SURGERY KIT$108

How this compares

$6,132 in reported general payments places this provider in the 90th percentile of 210 otolaryngology providers in Missouri.

See all otolaryngology providers in Missouri →

Medicare billing

Part B allowed, 2024

$158,737

Medicare patients

420

Services billed

1,998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Omeprazole	461	$11,217
Famotidine	488	$7,296
Ofloxacin	141	$5,559
Ipratropium Bromide	134	$4,345
CefuroximeCefuroxime Axetil	153	$2,691
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	112	$2,145
Nortriptyline Hcl	78	$1,033
Pantoprazole Sodium	66	$811
Clotrimazole	25	$624
Mupirocin	87	$572
Prednisone	181	$395
Fluconazole	21	$355
Fluticasone Propionate	18	$261
Montelukast Sodium	18	$256
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	35	$215

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Kirkwood

Sean BaileyKirkwood$5K
Joseph BradleyKirkwood$3K
Talon ManingasJoplin$314K
Ryan JacksonSaint Louis$284K
Ravindra UppaluriSaint Louis$168K
James GouldFestus$143K
John SchneiderSaint Louis$74K
Amit WaliaSaint Louis$21K
Bharat PanugantiSaint Louis$19K
Jeffrey SharonSt. Louis$18K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →